Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
University Library
Adelaide Festival of Ideas
Barr Smith Press
Friends of the University of Adelaide Library
Library Publications
Internal documents (Library staff only)
Library images
Library reports and papers
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 10 (Search time: 0.004 seconds).
previous
1
next
Item hits:
Preview
Issue Date
Title
Author(s)
2014
The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17
Sommeijer, D.
;
Karapetis, C.
;
Zalcberg, J.
;
Tu, D.
;
Jonker, D.
;
Simes, J.
;
Tebbutt, N.
;
Yip, D.
;
Price, T.
;
O'Callaghan, C.
2012
Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
Khattak, M.
;
Townsend, A.
;
Beeke, C.
;
Karapetis, C.
;
Luke, C.
;
Padbury, R.
;
Maddern, G.
;
Roder, D.
;
Price, T.
2013
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
Vickers, M.
;
Karapetis, C.
;
Tu, D.
;
O'Callaghan, C.
;
Price, T.
;
Tebbutt, N.
;
van Hazel, G.
;
Shapiro, J.
;
Pavlakis, N.
;
Gibbs, P.
;
Blondal, J.
;
Lee, U.
;
Meharchand, J.
;
Burkes, R.
;
Rubin, S.
;
Simes, J.
;
Zalcberg, J.
;
Moore, M.
;
Zhu, L.
;
Jonker, D.
2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Peeters, M.
;
Price, T.
;
Cervantes, A.
;
Sobrero, A.
;
Ducreux, M.
;
Hotko, Y.
;
Andre, T.
;
Chan, E.
;
Lordick, F.
;
Punt, C.
;
Strickland, A.
;
Wilson, G.
;
Ciuleanu, T.
;
Roman, L.
;
Van Cutsem, E.
;
Tzekova, V.
;
Collins, S.
;
Oliner, K.
;
Rong, A.
;
Gansert, J.
2011
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer
Price, T.
;
Hardingham, J.
;
Lee, C.
;
Weickhardt, A.
;
Townsend, A.
;
Wrin, J.
;
Chua, A.
;
Shivasami, A.
;
Cummins, M.
;
Murone, C.
;
Tebbutt, N.
2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX study
Tebbutt, N.
;
Wilson, K.
;
Gebski, V.
;
Cummins, M.
;
Zannino, D.
;
van Hazel, G.
;
Robinson, B.
;
Broad, A.
;
Ganju, V.
;
Ackland, S.
;
Forgeson, G.
;
Cunningham, D.
;
Saunders, M.
;
Stockler, M.
;
Chua, Y.
;
Zalcberg, J.
;
Simes, R.
;
Price, T.
2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancer
Weickhardt, A.
;
Price, T.
;
Chong, G.
;
Gebski, V.
;
Pavlakis, N.
;
Johns, T.
;
Azad, A.
;
Skrinos, E.
;
Fluck, K.
;
Dobrovic, A.
;
Salemi, R.
;
Scott, A.
;
Mariadason, J.
;
Tebbutt, N.
2011
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
Kotasek, D.
;
Tebbutt, N.
;
Desai, J.
;
Welch, S.
;
Siu, L.
;
McCoy, S.
;
Sun, Y.
;
Johnson, J.
;
Adewoye, A.
;
Price, T.
2015
Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant Therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial
Schmoll, H.
;
Tabernero, J.
;
Maroun, J.
;
de Braud, F.
;
Price, T.
;
Van Cutsem, E.
;
Hill, M.
;
Hoersch, S.
;
Rittweger, K.
;
Haller, D.
2015
Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancer
Peeters, M.
;
Oliner, K.
;
Price, T.
;
Cervantes, A.
;
Sobrero, A.
;
Ducreux, M.
;
Hotko, Y.
;
André, T.
;
Chan, E.
;
Lordick, F.
;
Punt, C.
;
Strickland, A.
;
Wilson, G.
;
Ciuleanu, T.
;
Roman, L.
;
Van Cutsem, E.
;
He, P.
;
Yu, H.
;
Koukakis, R.
;
Terwey, J.
;
et al.
Discover
Author
6
Tebbutt, N.
3
Karapetis, C.
3
Van Cutsem, E.
3
Zalcberg, J.
2
Cervantes, A.
2
Chan, E.
2
Ciuleanu, T.
2
Cummins, M.
2
Ducreux, M.
2
Gebski, V.
.
next >
Subject
10
Humans
10
Male
9
Adult
8
Antineoplastic Combined Chemother...
8
Colorectal Neoplasms
7
Aged, 80 and over
5
Antibodies, Monoclonal
5
Antibodies, Monoclonal, Humanized
5
Disease-Free Survival
5
Fluorouracil
.
next >
Date issued
2
2015
1
2014
1
2013
2
2012
2
2011
2
2010